Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manish Rathi

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Lupus|June 26, 2024
Critical peripheral ischemia: Higher prevalence in Indian systemic lupus erythematosus inception cohort for research (INSPIRE)Vineeta Shobha, Liza Rajasekhar, Sandra Manuel, et al.
The Journal of the Association of Physicians of India|September 27, 2019
Pulmonary and Ear, Nose and Throat (ENT) Involvement in ANCA-Associated Vasculitis at Diagnosis-Experience from a Tertiary Care Centre in North IndiaAman Sharma, Arjun Lakshman, Ram V Nampoothiri, et al.
Rheumatology International|February 6, 2022
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based reviewArun Prabhahar, G S R S N K Naidu, Prabhat Chauhan, et al.
Kidney International Reports|August 7, 2023
Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic RiskSachin Naik, Deeksha Pal, Shubham Shukla, et al.
Kidney International Reports|November 17, 2017
Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and CyclophosphamideRaja Ramachandran, Ashok Kumar Yadav, Vinod Kumar, et al.
International Journal of Rheumatic Diseases|December 20, 2016
Polyarteritis nodosa in north India: clinical manifestations and outcomesAman Sharma, Benzeeta Pinto, Aadhaar Dhooria, et al.
Rheumatology International|August 2, 2022
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyJoydeep Samanta, Gsrsnk Naidu, Prateek Deo, et al.
Neurology India|October 9, 2015
Giant cell arteritis in India: Report from a tertiary care center along with total published experience from IndiaAman Sharma, Vinay Sagar, Mahesh Prakash, et al.
Kidney International Reports|February 3, 2026
Corrigendum to "Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 10, Issue 11, November 2025, Pages 3785-3795]Raja Ramachandran, Prabhat Chauhan, Joyita Bharati, et al.
Kidney International Reports|November 24, 2025
Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous NephropathyRaja Ramachandran, Prabhat Chauhan, Joyita Bharati, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Lupus|June 26, 2024
Critical peripheral ischemia: Higher prevalence in Indian systemic lupus erythematosus inception cohort for research (INSPIRE)Vineeta Shobha, Liza Rajasekhar, Sandra Manuel, et al.
The Journal of the Association of Physicians of India|September 27, 2019
Pulmonary and Ear, Nose and Throat (ENT) Involvement in ANCA-Associated Vasculitis at Diagnosis-Experience from a Tertiary Care Centre in North IndiaAman Sharma, Arjun Lakshman, Ram V Nampoothiri, et al.
Rheumatology International|February 6, 2022
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based reviewArun Prabhahar, G S R S N K Naidu, Prabhat Chauhan, et al.
Kidney International Reports|August 7, 2023
Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic RiskSachin Naik, Deeksha Pal, Shubham Shukla, et al.
Kidney International Reports|November 17, 2017
Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and CyclophosphamideRaja Ramachandran, Ashok Kumar Yadav, Vinod Kumar, et al.
International Journal of Rheumatic Diseases|December 20, 2016
Polyarteritis nodosa in north India: clinical manifestations and outcomesAman Sharma, Benzeeta Pinto, Aadhaar Dhooria, et al.
Rheumatology International|August 2, 2022
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyJoydeep Samanta, Gsrsnk Naidu, Prateek Deo, et al.
Neurology India|October 9, 2015
Giant cell arteritis in India: Report from a tertiary care center along with total published experience from IndiaAman Sharma, Vinay Sagar, Mahesh Prakash, et al.
Kidney International Reports|February 3, 2026
Corrigendum to "Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 10, Issue 11, November 2025, Pages 3785-3795]Raja Ramachandran, Prabhat Chauhan, Joyita Bharati, et al.
Kidney International Reports|November 24, 2025
Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous NephropathyRaja Ramachandran, Prabhat Chauhan, Joyita Bharati, et al.
Pageof 16